Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 94

1.

Intravenous infusion of mesenchymal stem cells promotes functional recovery in a rat model of chronic cerebral infarction.

Namioka T, Namioka A, Sasaki M, Kataoka-Sasaki Y, Oka S, Nakazaki M, Onodera R, Suzuki J, Sasaki Y, Nagahama H, Kocsis JD, Honmou O.

J Neurosurg. 2018 Oct 1:1-8. doi: 10.3171/2018.5.JNS18140. [Epub ahead of print]

PMID:
30485210
2.

Intravenous infusion of mesenchymal stem cells for protection against brainstem infarction in a persistent basilar artery occlusion model in the adult rat.

Namioka A, Namioka T, Sasaki M, Kataoka-Sasaki Y, Oka S, Nakazaki M, Onodera R, Suzuki J, Sasaki Y, Nagahama H, Kocsis JD, Honmou O.

J Neurosurg. 2018 Oct 1:1-9. doi: 10.3171/2018.4.JNS173121. [Epub ahead of print]

PMID:
30485204
3.

Functional recovery after the systemic administration of mesenchymal stem cells in a rat model of neonatal hypoxia-ischemia.

Sakai T, Sasaki M, Kataoka-Sasaki Y, Oka S, Nakazaki M, Fukumura S, Kobayashi M, Tsutsumi H, Kocsis JD, Honmou O.

J Neurosurg Pediatr. 2018 Nov 1;22(5):513-522. doi: 10.3171/2018.5.PEDS1845.

PMID:
30074448
4.

Actin, alpha, cardiac muscle 1 (ACTC1) knockdown inhibits the migration of glioblastoma cells in vitro.

Wanibuchi M, Ohtaki S, Ookawa S, Kataoka-Sasaki Y, Sasaki M, Oka S, Kimura Y, Akiyama Y, Mikami T, Mikuni N, Kocsis JD, Honmou O.

J Neurol Sci. 2018 Sep 15;392:117-121. doi: 10.1016/j.jns.2018.07.013. Epub 2018 Jul 17.

PMID:
30055382
5.

[8. Evaluation of the Therapeutic Mechanisms in Regeneration Therapy for Cerebral Infarction Using Pre-clinical Magnetic Resonance Imaging].

Nagahama H, Suzuki J, Sasaki M, Nakazaki M, Honmou O.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2018;74(7):722-725. doi: 10.6009/jjrt.2018_JSRT_74.7.722. Japanese. No abstract available.

6.

Intravenous Infusion of Mesenchymal Stem Cells Alters Motor Cortex Gene Expression in a Rat Model of Acute Spinal Cord Injury.

Oshigiri T, Sasaki T, Sasaki M, Kataoka-Sasaki Y, Nakazaki M, Oka S, Morita T, Hirota R, Yoshimoto M, Yamashita T, Hashimoto-Torii K, Honmou O.

J Neurotrauma. 2019 Feb 1;36(3):411-420. doi: 10.1089/neu.2018.5793. Epub 2018 Aug 10.

PMID:
29901416
7.

Preservation of interhemispheric cortical connections through corpus callosum following intravenous infusion of mesenchymal stem cells in a rat model of cerebral infarction.

Nagahama H, Nakazaki M, Sasaki M, Kataoka-Sasaki Y, Namioka T, Namioka A, Oka S, Onodera R, Suzuki J, Sasaki Y, Kocsis JD, Honmou O.

Brain Res. 2018 Sep 15;1695:37-44. doi: 10.1016/j.brainres.2018.05.033. Epub 2018 May 23.

PMID:
29802840
8.

Accelerating Cell Therapy for Stroke in Japan: Regulatory Framework and Guidelines on Development of Cell-Based Products.

Houkin K, Shichinohe H, Abe K, Arato T, Dezawa M, Honmou O, Horie N, Katayama Y, Kudo K, Kuroda S, Matsuyama T, Miyai I, Nagata I, Niizuma K, Sakushima K, Sasaki M, Sato N, Sawanobori K, Suda S, Taguchi A, Tominaga T, Yamamoto H, Yamashita T, Yoshimine T; Working Group for Guidelines on Development of Cell-Based Products for the Treatment of Cerebral Infarction.

Stroke. 2018 Apr;49(4):e145-e152. doi: 10.1161/STROKEAHA.117.019216. Epub 2018 Mar 16. Review. No abstract available.

PMID:
29581346
9.

Intravenous infusion of mesenchymal stem cells reduces epileptogenesis in a rat model of status epilepticus.

Fukumura S, Sasaki M, Kataoka-Sasaki Y, Oka S, Nakazaki M, Nagahama H, Morita T, Sakai T, Tsutsumi H, Kocsis JD, Honmou O.

Epilepsy Res. 2018 Mar;141:56-63. doi: 10.1016/j.eplepsyres.2018.02.008. Epub 2018 Feb 14.

PMID:
29475054
10.

Digital Polymerase Chain Reaction Quantification of SERPINA1 Predicts Prognosis in High-Grade Glioma.

Ookawa S, Wanibuchi M, Kataoka-Sasaki Y, Sasaki M, Oka S, Ohtaki S, Noshiro S, Komatsu K, Akiyama Y, Mikami T, Mikuni N, Kocsis JD, Honmou O.

World Neurosurg. 2018 Mar;111:e783-e789. doi: 10.1016/j.wneu.2017.12.166. Epub 2018 Jan 5.

PMID:
29309973
11.

Intravenous Infusion of Bone Marrow-Derived Mesenchymal Stem Cells Reduces Erectile Dysfunction Following Cavernous Nerve Injury in Rats.

Matsuda Y, Sasaki M, Kataoka-Sasaki Y, Takayanagi A, Kobayashi K, Oka S, Nakazaki M, Masumori N, Kocsis JD, Honmou O.

Sex Med. 2018 Mar;6(1):49-57. doi: 10.1016/j.esxm.2017.10.005. Epub 2017 Dec 21.

12.

Cerebral aneurysm neck diameter is an independent predictor of progressive occlusion after stent-assisted coiling.

Nakazaki M, Nonaka T, Nomura T, Onda T, Yonemasu Y, Takahashi A, Hashimoto Y, Honda O, Oka S, Sasaki M, Daibo M, Honmou O.

Acta Neurochir (Wien). 2017 Jul;159(7):1313-1319. doi: 10.1007/s00701-017-3199-8. Epub 2017 May 9.

PMID:
28488070
13.

Elevated brain derived neurotrophic factor levels in plasma reflect in vivo functional viability of infused mesenchymal stem cells for stroke in rats.

Nakamura H, Sasaki Y, Sasaki M, Kataoka-Sasaki Y, Oka S, Nakazaki M, Namioka T, Namioka A, Onodera R, Suzuki J, Nagahama H, Mikami T, Wanibuchi M, Kocsis JD, Honmou O.

J Neurosurg Sci. 2019 Feb;63(1):42-49. doi: 10.23736/S0390-5616.17.03989-3. Epub 2017 Feb 8.

PMID:
28181779
14.

Co-expression of tissue factor and IL-6 in immature endothelial cells of cerebral cavernous malformations.

Noshiro S, Mikami T, Kataoka-Sasaki Y, Sasaki M, Ohnishi H, Ohtaki S, Wanibuchi M, Mikuni N, Kocsis JD, Honmou O.

J Clin Neurosci. 2017 Mar;37:83-90. doi: 10.1016/j.jocn.2016.12.023. Epub 2017 Jan 10.

PMID:
28087183
15.

Interleukin-13 receptor alpha 2 as a marker of poorer prognosis in high-grade astrocytomas.

Wanibuchi M, Kataoka-Sasaki Y, Sasaki M, Oka S, Otsuka Y, Yamaguchi M, Ohnishi H, Ohtaki S, Noshiro S, Ookawa S, Mikami T, Mikuni N, Honmou O.

J Neurosurg Sci. 2018 Jun;62(3):239-244. doi: 10.23736/S0390-5616.16.03793-0. Epub 2017 Jan 12.

PMID:
28079349
16.

Intravenous infusion of mesenchymal stem cells inhibits intracranial hemorrhage after recombinant tissue plasminogen activator therapy for transient middle cerebral artery occlusion in rats.

Nakazaki M, Sasaki M, Kataoka-Sasaki Y, Oka S, Namioka T, Namioka A, Onodera R, Suzuki J, Sasaki Y, Nagahama H, Mikami T, Wanibuchi M, Kocsis JD, Honmou O.

J Neurosurg. 2017 Oct;127(4):917-926. doi: 10.3171/2016.8.JNS16240. Epub 2017 Jan 6.

PMID:
28059661
17.

Synergic Effects of Rehabilitation and Intravenous Infusion of Mesenchymal Stem Cells After Stroke in Rats.

Sasaki Y, Sasaki M, Kataoka-Sasaki Y, Nakazaki M, Nagahama H, Suzuki J, Tateyama D, Oka S, Namioka T, Namioka A, Onodera R, Mikami T, Wanibuchi M, Kakizawa M, Ishiai S, Kocsis JD, Honmou O.

Phys Ther. 2016 Nov;96(11):1791-1798. Epub 2016 May 12.

PMID:
27174259
18.

Intravenous infusion of mesenchymal stem cells promotes functional recovery in a model of chronic spinal cord injury.

Morita T, Sasaki M, Kataoka-Sasaki Y, Nakazaki M, Nagahama H, Oka S, Oshigiri T, Takebayashi T, Yamashita T, Kocsis JD, Honmou O.

Neuroscience. 2016 Oct 29;335:221-31. doi: 10.1016/j.neuroscience.2016.08.037. Epub 2016 Aug 30.

PMID:
27586052
19.

Biological relevance of tissue factor and IL-6 in arteriovenous malformations.

Noshiro S, Mikami T, Kataoka-Sasaki Y, Sasaki M, Hashi K, Ohtaki S, Wanibuchi M, Mikuni N, Kocsis JD, Honmou O.

Neurosurg Rev. 2017 Jul;40(3):359-367. doi: 10.1007/s10143-016-0780-1. Epub 2016 Aug 19.

PMID:
27542852
20.

[Phase III clinical trial using autologous mesenchymal stem cells for stroke patients].

Honmou O.

Nihon Rinsho. 2016 Apr;74(4):649-54. Review. Japanese.

PMID:
27333754

Supplemental Content

Loading ...
Support Center